v3.24.2.u1
Condensed Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Operating expenses:        
Research and development $ 1,542 $ 1,925 $ 2,799 $ 3,263
General and administrative 1,492 1,450 2,711 3,373
Total operating expenses 3,034 3,375 5,510 6,636
Loss from operations (3,034) (3,375) (5,510) (6,636)
Other income/(expenses), net:        
Interest and dividend income 138 50 175 54
Change in fair value of common warrant liability 507 1,573 1,870 1,573
Transaction costs allocated to common warrant liability (575) (575)
Total other income/(expenses), net 645 1,048 2,045 1,052
Net loss (2,389) (2,327) (3,465) (5,584)
Other comprehensive loss:        
Comprehensive loss $ (2,389) $ (2,327) $ (3,465) $ (5,584)
Net loss per share, basic $ (0.10) $ (0.22) $ (0.18) $ (0.57)
Net loss per share, diluted $ (0.10) $ (0.22) $ (0.18) $ (0.57)
Weighted-average shares of common stock outstanding, basic 24,049,113 10,655,155 19,498,306 9,881,371
Weighted-average shares of common stock outstanding, diluted 24,049,113 10,655,155 19,498,306 9,881,371

Source